The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Histological and biological evolution of human premalignant breast disease.
Abstract
Most human invasive breast cancers (IBCs) appear to develop over long periods of time from certain pre-existing benign lesions. Of the many types of benign lesions in the human breast, only a few appear to have significant premalignant potential. The best characterized of these include atypical hyperplasias and in situ carcinomas and both categories are probably well on along the evolutionary pathway to IBC. Very little is known about earlier premalignant alterations. All types of premalignant breast lesions are relatively common but only a small proportion appear to progress to IBC. They are currently defined by their histological features and their prognosis is imprecisely estimated from indirect epidemiological evidence. Although lesions within specific categories look alike, they must possess underlying biological differences causing some to remain stable and others to progress. Recent studies suggest that they evolve by highly diverse genetic mechanisms and research into these altered pathways may identify specific early defects that can be targeted to prevent premalignant lesions from developing or becoming cancerous. It is far more rational to think that breast cancer can be prevented than cured once it has developed fully. This review discusses histological models of human premalignant breast disease that provide the framework for scientific investigations into the biological alterations behind them and examples of specific biological alterations that appear to be particularly important.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
Dupont, W. D., & Page, D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120303 · Cited by 1,829
Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk
Pike, M. C., Spicer, D. V., Dahmoush, L., & Press, M. F. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036102 · Cited by 1,010
Atypical hyperplastic lesions of the female breast. A long-term follow-up study
Page, D. L., Dupont, W. D., Rogers, L. W., & Rados, M. S. (1985) · Cancer · doi:10.1002/1097-0142(19850601)55:11<2698::aid-cncr2820551127>3.0.co;2-a · Cited by 961
Nuclear receptor coactivators and corepressors
Horwitz, K. B. (1996) · Molecular Endocrinology · doi:10.1210/me.10.10.1167 · Cited by 942
Neu-Protein Overexpression in Breast Cancer
van de Vijver, M. J., Peterse, J. L., Mooi, W. J., Wisman, P., Lomans, J., Dalesio, O., & Nusse, R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811103191902 · Cited by 860
Fisher, E. R., Sass, R., Fisher, B., Wickerham, L., Paik, S. M., & COLLABORATING NSABP INVESTIGATORS (1986) · Cancer · doi:10.1002/1097-0142(19860115)57:2<197::aid-cncr2820570203>3.0.co;2-n · Cited by 812
(1975) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/55.2.231 · Cited by 750
Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture.
Henderson, B. E., Ross, R. K., & Bernstein, L. (1988) · PubMed · Cited by 700
Dissociation between steroid receptor expression and cell proliferation in the human breast.
Clarke, R. B., Howell, A., Potten, C. S., & Anderson, E. J. (1997) · PubMed · Cited by 625
Intraductal carcinoma of the breast: Follow-up after biopsy only
Page, D. L., Dupont, W. D., Rogers, L. W., & Landenberger, M. (1982) · Cancer · doi:10.1002/1097-0142(19820215)49:4<751::aid-cncr2820490426>3.0.co;2-y · Cited by 608
Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas
Deng, G., Lu, Y., Zlotnikov, G., Thor, A. D., & Smith, H. S. (1996) · Science · doi:10.1126/science.274.5295.2057 · Cited by 582
Breast cancer risk associated with proliferative breast disease and atypical hyperplasia
Dupont, W. D., Parl, F. F., Hartmann, W. H., Brinton, L. A., Winfield, A. C., Worrell, J. A., Schuyler, P. A., & Plummer, W. D. (1993) · Cancer · doi:10.1002/1097-0142(19930215)71:4<1258::aid-cncr2820710415>3.0.co;2-i · Cited by 528
A Prospective Study of Benign Breast Disease and the Risk of Breast Cancer
London, S. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480070057030 · Cited by 504
Venter, D., Kumar, S., Tuzi, N., & Gullick, W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92736-x · Cited by 404
Russo, J., Ao, X., Grill, C., & Russo, I. H. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006186719322 · Cited by 361
Analysis of Loss of Heterozygosity in 399 Premalignant Breast Lesions at 15 Genetic Loci
O'Connell, P., Pekkel, V., Allred, D. C., Fuqua, S. A. W., Osborne, C. K., & Clark, G. M. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.9.697 · Cited by 340
Self-citationMCF10AT: a model for the evolution of cancer from proliferative breast disease.
Dawson, P. J., Wolman, S. R., Tait, L. R., Heppner, G. H., & Miller, F. R. (1996) · Europe PMC (PubMed Central) · Cited by 314
The effect of age and menstrual cycle upon proliferative activity of the normal human breast
Potten, C., Watson, R., Williams, G., Tickle, S., Roberts, S., Harris, M., & Howell, A. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.185 · Cited by 311
A Correlative Morphologic Study of Human Breast and Endometrium in the Menstrual Cycle
Longacre, T. A., & Bartow, S. A. (1986) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198606000-00003 · Cited by 286
Genetic basis for p53 overexpression in human breast cancer.
Davidoff, A. M., Humphrey, P. A., Iglehart, J. D., & Marks, J. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.5006 · Cited by 285
Estrogen Receptor-Positive Proliferating Cells in the Normal and Precancerous Breast
Shoker, B. S., Jarvis, C., Clarke, R. B., Anderson, E., Hewlett, J., Davies, M. P. A., Sibson, D. R., & Sloane, J. P. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65498-3 · Cited by 278
Bártek, J., Bártková, J., Vojtěšek, B., Stašková, Z., Rejthar, A., Kovařík, J., & Lane, D. P. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910460515 · Cited by 276
Implications of the p53 tumor-suppressor gene in clinical oncology.
Chang, F., Syrjänen, S., & Syrjänen, K. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.4.1009 · Cited by 258
Ravdin, P. M., & Chamness, G. C. (1995) · Gene · doi:10.1016/0378-1119(94)00866-q · Cited by 254
Estrogen Receptor Expression in Benign Breast Epithelium and Breast Cancer Risk
Khan, S. A., Rogers, M. A. M., Khurana, K. K., Meguid, M. M., & Numann, P. J. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.1.37 · Cited by 251
Influence of age and parity on the development of the human breast
Russo, J., Rivera, R., & Russo, I. H. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01833517 · Cited by 235
PETERSEN, O. W., Høyer, P. E., & van Deurs, B. (1987) · PubMed · Cited by 229
Proliferative and secretory activity in human breast during natural and artificial menstrual cycles.
Going, J. J., Anderson, T. J., Battersby, S., & Macintyre, C. C. A. (1988) · Europe PMC (PubMed Central) · Cited by 208
Lakhani, S. R., Collins, N., Stratton, M. R., & Sloane, J. P. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.611 · Cited by 204
Estrogen and progesterone receptors in the normal female breast.
Ricketts, D., Turnbull, L. A., Ryall, G., bakhshi, R. K., Rawson, N. S. B., Gazet, J.-C., Nolan, C., & Coombes, R. C. (1991) · PubMed · Cited by 197
c-erbB-2 expression in benign and malignant breast disease
Gusterson, B., Machin, L., Gullick, W., Gibbs, N., Powles, T., Elliott, C., Ashley, S., Monaghan, P., & Harrison, S. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.239 · Cited by 190
Abnormal expression of wild type p53 protein in normal cells of a cancer family patient
Barnes, D. M., Gillett, C. E., Bobrow, L. G., Hanby, A. M., Mohammed, S., Hodgson, S., Leigh, I. M., Purkis, T., MacGeoch, C., Spurr, N. K., et al. (1992) · The Lancet · doi:10.1016/0140-6736(92)92354-i · Cited by 190
Meyer, J. S. (1977) · Human Pathology · doi:10.1016/s0046-8177(77)80066-x · Cited by 186
The prevalence of carcinoma in situ in normal and cancer-associated breasts
Alpers, C. E., & Wellings, S. R. (1985) · Human Pathology · doi:10.1016/s0046-8177(85)80251-3 · Cited by 170
Chromosomal Alterations in Ductal Carcinomas In Situ and Their In Situ Recurrences
Waldman, F. M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.4.313 · Cited by 164
Genetic divergence in the clonal evolution of breast cancer.
Fujii, H., Marsh, C., Cairns, P., Sidransky, D., & Gabrielson, E. (1996) · PubMed · Cited by 163
Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ
Bartkova, J., Barnes, D. M., Millis, R. R., & Gullick, W. J. (1990) · Human Pathology · doi:10.1016/0046-8177(90)90154-w · Cited by 159
Radford, D. M., Fair, K., Phillips, N. J., Ritter, J. H., Steinbrueck, T., Holt, M. S., & Donis-Keller, H. (1995) · PubMed · Cited by 159
Poller, D. N., Roberts, E., Bell, J. A., Elston, C. W., Blamey, R. W., & Ellis, I. O. (1993) · Human Pathology · doi:10.1016/0046-8177(93)90157-c · Cited by 150
The p53 tumor suppressor gene in breast cancer
Elledge, R. M., & Allred, D. C. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666204 · Cited by 146
Self-citationExpression of p53 protein in infiltrating and in‐situ breast carcinomas
Walker, R. A., Dearing, S. J., Lane, D. P., & Varley, J. M. (1991) · The Journal of Pathology · doi:10.1002/path.1711650303 · Cited by 141
Thymidine labeling index and Ki-67 growth fraction in lesions of the breast.
Kamel, O. W., Franklin, W. A., Ringus, J., & Meyer, J. S. (1989) · Europe PMC (PubMed Central) · Cited by 137
Aldaz, C. M., Chen, T.-X., Şahin, A. A., Cunningham, J. G., & Bondy, M. L. (1995) · PubMed · Cited by 137
Transforming Growth Factor-β and Breast Cancer Risk in Women With Mammary Epithelial Hyperplasia
Gobbi, H., Dupont, W. D., Simpson, J. F., Plummer, W. D., Schuyler, P. A., Olson, S. J., Arteaga, C. L., & Page, D. L. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.24.2096 · Cited by 130
The classification of ductal carcinoma in situ and its association with biological markers.
Bobrow, L. G., Happerfield, L. C., Gregory, W. M., Springall, R., & Millis, R. R. (1994) · PubMed · Cited by 127
Ramachandra, S., Machin, L., Ashley, S., Monaghan, P., & Gusterson, B. A. (1990) · The Journal of Pathology · doi:10.1002/path.1711610104 · Cited by 125
Zhuang, Z., Merino, M. J., Chuaqui, R., Liotta, L. A., & Emmert-Buck, M. R. (1995) · PubMed · Cited by 125
Lodato, R. F., Maguire, H. C., Jr., Greene, M. I., et al. (1990) · PubMed · Cited by 122
Molecular genetic studies of early breast cancer evolution
O'Connell, P., Pekkel, V., Fuqua, S. A. W., Osborne, C. K., & Allred, D. C. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666201 · Cited by 118
Self-citationImmunohistochemical Detection of c-erbB-2 and p53 in Benign Breast Disease and Breast Cancer Risk
Rohan, T. E., Hartwick, W. J., Miller, A. B., & Kandel, R. A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.17.1262 · Cited by 106
Role of differentiation in the pathogenesis and prevention of breast cancer
Russo, J., & Russo, I. H. (1997) · Endocrine Related Cancer · doi:10.1677/erc.0.0040007 · Cited by 103
c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma.
Somerville, J. E., Clarke, L., & Biggart, J. D. (1992) · Journal of Clinical Pathology · doi:10.1136/jcp.45.1.16 · Cited by 101
Ahmadian, M., Wistuba, I. I., Fong, K. M., Behrens, C., Kodagoda, D. R., Saboorian, M. H., Shay, J. W., Tomlinson, G. E., Blum, J. L., Minna, J. D., et al. (1997) · PubMed · Cited by 85
Joshi, K., Smith, J. A. H., Perusinghe, N. P., et al. (1986) · PubMed · Cited by 84
Tsuda, H., Iwaya, K., Fukutomi, T., & Hirohashi, S. (1993) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1993.tb00149.x · Cited by 84
Anatomic indicators (histologic and cytologic) of increased breast cancer risk
Page, D. L., & Dupont, W. D. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf00666428 · Cited by 82
Influence of age and gland topography on cell kinetics of normal human breast tissue.
Russo, J., Calaf, G. M., Roi, L. D., & Russo, I. H. (1987) · PubMed · Cited by 77
Rudland, P. S. (1993) · PubMed · Cited by 53
Eriksson, E. T., Schimmelpenning, H., Aspenblad, U., Zetterberg, A., & Auer, G. (1994) · Human Pathology · doi:10.1016/0046-8177(94)90040-x · Cited by 49
Dillon, E., Boer, W. B. D., Jm, P., & Turbett, G. R. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.357 · Cited by 44
Domagała, W., Markiewski, M. M., Kubiak, R., Bartkowiak, J., & Osborn, M. (1993) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01606541 · Cited by 42
p53 alterations in all stages of breast cancer
Davidoff, A. M., Kerns, B. M., Pence, J. C., Marks, J. R., & Iglehart, J. D. (1991) · Journal of Surgical Oncology · doi:10.1002/jso.2930480409 · Cited by 40
The p185 erbB2 protein is localized on cell organelles involved in cell motility
Potter, C. R. D., & Quatacker, J. R. (1993) · Clinical & Experimental Metastasis · doi:10.1007/bf00054936 · Cited by 32
Cited by
Gene expression profiles of human breast cancer progression
Ma, X.-J., Salunga, R., Tuggle, J. T., Gaudet, J., Enright, E., McQuary, P., Payette, T., Pistone, M., Stecker, K., Zhang, B. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931261100 · Cited by 887
Ductal Carcinoma in Situ of the Breast
Burstein, H. J., Polyak, K., Wong, J. S., Lester, S. C., & Kaelin, C. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031301 · Cited by 759
Breast cancer: origins and evolution
Polyak, K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33295 · Cited by 697
Gene expression profiling of the tumor microenvironment during breast cancer progression
Ma, X.-J., Dahiya, S., Richardson, E., Erlander, M., & Sgroi, D. C. (2009) · Breast Cancer Research · doi:10.1186/bcr2222 · Cited by 629
Biology of Progesterone Receptor Loss in Breast Cancer and Its Implications for Endocrine Therapy
Cui, X., Schiff, R., Arpino, G., Osborne, C. K., & Lee, A. V. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.004 · Cited by 514
Metadata
- Authors
- Allred, D. C., Mohsin, S. K., & Fuqua, S. A.
- Venue
- Endocrine-related cancer
- Publisher
- Bioscientifica
- Published
- 2001-03
- Volume
- 8
- Issue
- 1
- Pages
- 47-61
- ISSN
- 1351-0088 (ISSN-L)
- OpenAlex
- W2110279965
- Cited by
- 416
- References
- 65
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.